These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2304962)

  • 1. Immune status of unselected methadone maintained former heroin addicts.
    Kreek MJ; Khuri E; Flomenberg N; Albeck H; Ochshorn M
    Prog Clin Biol Res; 1990; 328():445-8. PubMed ID: 2304962
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
    Novick DM; Ochshorn M; Ghali V; Croxson TS; Mercer WD; Chiorazzi N; Kreek MJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):606-10. PubMed ID: 2788218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune status.
    Kreek MJ; Khuri E; Fahey L; Miescher A; Arns P; Spagnoli D; Craig J; Millman R; Harte EH
    NIDA Res Monogr; 1986; 67():307-9. PubMed ID: 3092083
    [No Abstract]   [Full Text] [Related]  

  • 4. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P; Franchi S; Gerra G; Leccese V; Panerai AE; Somaini L
    Brain Behav Immun; 2008 May; 22(4):606-13. PubMed ID: 18294814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological function in active heroin addicts and methadone-maintained former addicts: observations and possible mechanisms.
    Kreek MJ
    NIDA Res Monogr; 1990; 105():75-81. PubMed ID: 1876153
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic.
    Kreek MJ
    NIDA Res Monogr; 1990; 96():192-219. PubMed ID: 2233996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological status in heroin addicts: effects of methadone maintenance treatment.
    Lazzarin A; Mella L; Trombini M; Uberti-Foppa C; Franzetti F; Mazzoni G; Galli M
    Drug Alcohol Depend; 1984 Mar; 13(2):117-23. PubMed ID: 6609805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of immune functions in heroin addicts and heroin withdrawal subjects.
    Govitrapong P; Suttitum T; Kotchabhakdi N; Uneklabh T
    J Pharmacol Exp Ther; 1998 Aug; 286(2):883-9. PubMed ID: 9694946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of the effect of methadone on natural killer cell activity.
    Ochshorn M; Novick DM; Kreek MJ
    Isr J Med Sci; 1990 Aug; 26(8):421-5. PubMed ID: 2401603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.
    Adelson MO; Novick DM; Khuri E; Albeck H; Hahn EF; Kreek MJ
    Isr J Med Sci; 1994 Sep; 30(9):679-84. PubMed ID: 8088979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hypermacroglobulinemia in methadone maintained and other narcotic addicts.
    Cushman P
    Proc Natl Conf Methadone Treat; 1973; 1():515-22. PubMed ID: 4215976
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological studies in methadone maintained patients.
    Cushman P; Gupta S; Grieco MH
    Int J Addict; 1977 Apr; 12(2-3):241-53. PubMed ID: 326684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma testosterone levels during chronic heroin use and protracted abstinence: study of Hong Kong addicts.
    Mendelson JH; Mello NK
    NIDA Res Monogr; 1978; (19):142-8. PubMed ID: 106283
    [No Abstract]   [Full Text] [Related]  

  • 15. [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].
    Brugo MA; Guffanti A; Guzzetti S; Pedretti D; Stringhetti M; Confalonieri F
    Boll Ist Sieroter Milan; 1983; 62(6):517-23. PubMed ID: 6234006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semen evaluation in heroin and methadone addicts.
    Ragni G; De Lauretis L; Gambaro V; Di Pietro R; Bestetti O; Recalcati F; Papetti C
    Acta Eur Fertil; 1985; 16(4):245-9. PubMed ID: 4072581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum leptin levels in patients with heroin addiction, the effect of one year of methadone substitution].
    Wilczek H; Haluzík M; Svobodová J; Parízková J
    Vnitr Lek; 2004 Apr; 50(4):282-5. PubMed ID: 15214298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F; Manzato E; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New treatment strategies in the drug withdrawal of heroin addicts].
    Patti F; Marano P; Giammona G; Rampello L; De Simone D; Nicoletti F
    Acta Neurol (Napoli); 1986 Aug; 8(4):447-54. PubMed ID: 3776725
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experiences with methadone maintenance in young adults (rehabilitation of heroin addicts with methadone: the public health approach versus the individual perspective).
    Johnson B; Corman AG; Khantzian EJ; Long J
    Proc Natl Conf Methadone Treat; 1973; 1():601-9. PubMed ID: 4808208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.